Facts and Stats
Categorizing Skin Cancer
A knowledge of the different types of skin cancer can help you remain vigilant.
by Bradley Jones
How Long Do Immunotherapy Side Effects Last?
For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.
by Anna Goshua
Worth the Wait
Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
Our Own Words
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
Still in the Game
ESPN reporter Holly Rowe worked through melanoma treatment.
by Lindsey Konkel
Dissecting Mental Illness
Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.
by Marci A. Landsmann
Pembrolizumab Shows Further Promise for Melanoma
In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.
by Brad Jones
Tackling Drug Resistance
Researchers are studing new ways to keep treatments working longer.
by Stephen Ornes
Living in the Here and Now
A metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
Cancer Immunotherapies Continue to Make Headway
Drugs that harness the power of the immune system gain new approvals.
by Alexandra Goho